SCHEMBL2065832

SCHEMBL2065832

[O]S(=O)(=O)c1ccc(OS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.67
MAPT P10636 2/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
MAOB P27338 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
CA12 O43570 2/20 0.48
CA2 P00918 2/20 0.48
ADAMTS4 O75173 1/20 0.47
ENPP3 O14638 5/20 0.47
ENPP1 P22413 5/20 0.47
ENPP2 Q13822 3/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.45
MAPK1 P28482 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9333331 0.86 TDP1 (0.69) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL19146 0.85 TDP1 (0.73) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL7981247 0.85 TDP1 (0.73) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL28479355 0.84 TDP1 (0.67) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL9309112 0.83 TDP1 (0.71) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL28934632 0.83 TDP1 (0.70) TDP1MAPTNPC1RAB9AMAOB
Ammonia Solution, Strong SCHEMBL28247173 0.83 TDP1 (0.70) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL1674227 0.83 TDP1 (0.70) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL28184027 0.83 TDP1 (0.70) TDP1MAPTNPC1RAB9AMAOB
SCHEMBL28075403 0.83 TDP1 (0.70) TDP1MAPTNPC1RAB9AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148053-B2 DNA sequenceing, biochemical immobilization, and genetic diagnosis; forming monomolecular film using (alkoxyalkoxy)alkylsilane(triol and/or halide) such as 10-(methoxymethoxy)dodecyltrimethoxysilane which forms hydroxyl groups when exposed to acid; forming polysulfonates; radiation with high energy beams SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-04-03 US disclosed
US-7494760-B2 Photoacid generators, chemically amplified resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-02-24 US disclosed
US-20080233309-A1 Method for manufacturing substrate for making microarray SHIN-ETSU CHEMICAL CO., LTD. (JP) 2008-09-25 US disclosed
US-20070287096-A1 Photoacid generators, chemically amplified resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. 2007-12-13 US disclosed
US-6916591-B2 Photoacid generators, chemically amplified resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-07-12 US disclosed
US-20030215738-A1 Photoacid generators, chemically amplified resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030215738-A1 Photoacid generators, chemically amplified resist compositions, and patterning process CCNH, PAH, POLH TDP1 2871/4885MAPT 4325/4885NPC1 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.